Inhibiting the transient receptor potential al ion channel
US11161849B2 · kind B2 · utility
0Cited by
4References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 30, 2019 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | Feb 14, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.